Monsanto the disposition of product lines unrelated to agriculture. In 1985, Monsanto acquired G. D. Searle & Company, a life sciences company that focused on pharmaceuticals, agriculture and animal health. In 1993, its Searle division filed a patent application for Celebrex, which in 1998 became the first selective COX‑2 inhibitor to be approved by the U.S. Food and Drug Administration (FDA). Celebrex became a blockbuster drug and was often mentioned as a key reason for Pfizer's acquisition of Monsanto's pharmaceutical business in 2002. In 1994, Monsanto introduced a recombinant version of bovine somatotropin, brand-named Posilac. Monsanto later sold this business to
Castle of Monsanto Castle of Monsanto The Castle of Monsanto () is a medieval castle located in the civil parish of Monsanto e Idanha-a-Velha, in the municipality of Idanha-a-Nova, Portuguese district of Castelo Branco. The site was likely the location of fortified settlement during prehistory. Legend suggests that during the 2nd century a castro was taken and colonized on the hilltop of Mons Sanctus, by Roman Praetor Lucius Aemilius Paullus. The castro was destroyed and progressively settled by settlers from Idanha-a-Velha. Between the 5th and 11th century was occupied by Visigoths and Arabs. In order to building a defensive line and strengthen his